Breaking News Instant updates and real-time market news.

RARX

RA Pharmaceuticals

$19.86

-0.94 (-4.52%)

06:09
02/08/19
02/08
06:09
02/08/19
06:09

RA Pharmaceuticals initiated with a Buy at Stifel

Stifel analyst Stephen Willey started RA Pharmaceuticals with a Buy rating and $55 price target. The positive Phase 2 proof-of-concept zilucoplan data generated in generalized myasthenia gravis and paroxysmal nocturnal hemoglobinuria "cement the validity of the zilucoplan value proposition and significantly de-risk" future Phase 3 development plans, Willey tells investors in a research note. He believes RA shares at current levels remain "significantly underappreciated by investors."

RARX RA Pharmaceuticals
$19.86

-0.94 (-4.52%)

12/10/18
PIPR
12/10/18
NO CHANGE
PIPR
Overweight
Piper says RA Pharma data may be competitive to Alexion, but questions remain
After RA Pharmaceuticals (RARX) reported top-line results from its Phase 2 trial of zilucoplan in generalized myasthenia gravis, or gMG, Piper Jaffray analyst Christopher Raymond said the data generally looks more competitive than he would have expected. However, more details on patient background and safety are needed to make a direct comparison to Alexion's (ALXN) Soliris, said Raymond, who thinks RA's program is "worth monitoring." He keeps an Overweight rating on Alexion shares, which are down 1% to $114.18 in early trading.
12/10/18
JEFF
12/10/18
NO CHANGE
Target $40
JEFF
Buy
RA Pharmaceuticals price target raised to $40 from $22 at Jefferies
Jefferies boosts its price target for RA Pharmaceuticals to a Street-high $40 following this morning's positive top-line results from the company's Phase 2 clinical trial evaluating zilucoplan for the treatment of generalized myasthenia gravis.
12/10/18
RBCM
12/10/18
NO CHANGE
RBCM
Outperform
RA Pharmaceuticals could be strategic target for Alexion, says RBC Capital
RBC Capital analyst Kennen MacKay believes RA Pharmaceuticals' (RARX) zilucoplan gMG data "should impress even the skeptics," but he has received questions about why the stock hasn't inflected higher on data that left him "overall highly impressed." He believes the recent run-up of the stock into the data suggests anticipation of a positive result and also thinks the upside has likely been limited by some anticipation for a dilutive financing. Commenting on why the news "isn't more negative" for Alexion (ALXN), MacKay added that he anticipates that Alexion could have strategic interest in an acquisition of RA, with sufficient financial flexibility to pursue a deal, as the latter gets closer to commercialization. MacKay maintains an Outperform rating on RA Pharmaceuticals shares.
12/11/18
RHCO
12/11/18
NO CHANGE
Target $35
RHCO
Buy
RA Pharmaceuticals price target raised to $35 from $28 at SunTrust
SunTrust analyst Edward Nash raised his price target on RA Pharmaceuticals to $35 and kept his Buy rating after its positive top-line results from a Phase II zilucoplan trial that are "comparable, if not better, to Soliris' Phase III REGAIN data." The analyst notes that the patients in the trial "did not require rescue therapy" and that the drug's safety profile was "mild". Nash believes that "zilucoplan is well positioned to treat broader generalized myasthenia gravis, or gMG, patients than Soliris, given its subQ delivery and a more accessible pricing."

TODAY'S FREE FLY STORIES

USCR

U.S. Concrete

$50.87

-0.96 (-1.85%)

05:04
07/18/19
07/18
05:04
07/18/19
05:04
Downgrade
U.S. Concrete rating change  »

U.S. Concrete downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 13

    Nov

AMD

AMD

$33.59

-0.23 (-0.68%)

, INTC

Intel

$49.39

0.22 (0.45%)

04:59
07/18/19
07/18
04:59
07/18/19
04:59
Downgrade
AMD downgraded to Neutral from Buy at Mizuho »

Mizuho analyst Vijay…

AMD

AMD

$33.59

-0.23 (-0.68%)

INTC

Intel

$49.39

0.22 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 7/13 Jobless…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

GMRE

Global Medical REIT

$10.51

-0.15 (-1.41%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Global Medical REIT management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

TORC

ResTORbio

$10.42

0.19 (1.86%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
ResTORbio management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SUPV

Grupo Supervielle

$8.12

0.13 (1.63%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Grupo Supervielle management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

July Philadelphia Fed…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Leading Indicators to be reported at 10:00 »

June Leading Indicators…

CAMP

CalAmp

$10.82

-0.46 (-4.08%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
CalAmp participates in a conference call with Northland »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/12 EIA Natural…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

CASY

Casey's General Stores

$160.43

0.08 (0.05%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Casey's General Stores management to meet with Northcoast »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 13

    Nov

OPNT

Opiant Pharmaceuticals

$13.24

-0.25 (-1.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Opiant Pharmaceuticals management to meet with Northland »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

ACAD

Acadia

$25.56

-0.72 (-2.74%)

, BIIB

Biogen

$229.39

-2.17 (-0.94%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Alzheimer's Association to hold a conference »

Alzheimer's…

ACAD

Acadia

$25.56

-0.72 (-2.74%)

BIIB

Biogen

$229.39

-2.17 (-0.94%)

CRL

Charles River

$135.30

0.08 (0.06%)

DGX

Quest Diagnostics

$100.18

-1.28 (-1.26%)

ESALY

Eisai

$0.00

(0.00%)

PKI

PerkinElmer

$95.10

-0.24 (-0.25%)

RHHBY

Roche

$0.00

(0.00%)

MRK

Merck

$81.93

0.36 (0.44%)

NSTG

NanoString

$30.44

-0.06 (-0.20%)

PRAH

PRA Health

$98.05

-0.43 (-0.44%)

QTRX

Quanterix

$31.45

0.37 (1.19%)

SYNH

Syneos Health

$47.64

-1.07 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

  • 31

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 13

    Sep

  • 16

    Sep

  • 20

    Sep

  • 02

    Oct

  • 04

    Nov

CGC

Canopy Growth

$36.57

1.015 (2.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Canopy Growth management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
The Brookings Institution to hold a conference on the US-China Trade War »

The Global Economy &…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
House Judiciary Committee to hold a hearing »

The Subcommittee on…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

8-Week Bill Auction to be…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/17 Fed Balance…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

UBSFY

Ubisoft

$0.00

(0.00%)

, TTWO

Take-Two

$117.64

0.15 (0.13%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

UBSFY

Ubisoft

$0.00

(0.00%)

TTWO

Take-Two

$117.64

0.15 (0.13%)

NTDOY

Nintendo

$0.00

(0.00%)

GME

GameStop

$4.39

-0.245 (-5.29%)

EA

Electronic Arts

$89.72

0.15 (0.17%)

ATVI

Activision Blizzard

$46.69

-0.29 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 30

    Jul

  • 05

    Aug

  • 08

    Aug

  • 08

    Aug

  • 05

    Sep

  • 13

    Nov

GLMD

Galmed

$6.30

-0.2 (-3.08%)

, CBAY

CymaBay

$6.39

-0.15 (-2.29%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold a KOL luncheon meeting »

Biotech Analysts Young…

GLMD

Galmed

$6.30

-0.2 (-3.08%)

CBAY

CymaBay

$6.39

-0.15 (-2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
William Blair enterprise & cloud infrastructure analyst to hold a group luncheon »

Enterprise & Cloud…

DOVA

Dova Pharmaceuticals

$16.01

-0.06 (-0.37%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Dova Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.